Detalhe da pesquisa
1.
INCIDENCE AND RISK FACTORS OF INTRAOCULAR INFLAMMATION AFTER BROLUCIZUMAB TREATMENT IN JAPAN: A Multicenter Age-Related Macular Degeneration Study.
Retina
; 44(4): 714-722, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38016089
2.
Short-term outcomes of intravitreal faricimab for treatment-naïve neovascular age-related macular degeneration.
Graefes Arch Clin Exp Ophthalmol
; 261(10): 2945-2952, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37195339
3.
Relationship between pulsation of posterior vortex vein, choroidal thickness, and choroidal vascular hyperpermeability in polypoidal choroidal vasculopathy.
Graefes Arch Clin Exp Ophthalmol
; 261(12): 3475-3480, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37615698
4.
RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Review of Real-World Evidence.
Retina
; 43(7): 1051-1063, 2023 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36893438
5.
A new insight into pachychoroid diseases: Remodeling of choroidal vasculature.
Graefes Arch Clin Exp Ophthalmol
; 260(11): 3405-3417, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-35575932
6.
Choroidal alterations during the clinical course of commotio retinae.
Graefes Arch Clin Exp Ophthalmol
; 260(1): 65-71, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34379185
7.
Comparison of the regressive effects of aflibercept and brolucizumab on pigment epithelial detachment.
BMC Ophthalmol
; 22(1): 387, 2022 Sep 29.
Artigo
Inglês
| MEDLINE | ID: mdl-36175862
8.
Intravitreal Aflibercept versus Brolucizumab for Treatment-Naive Neovascular Age-Related Macular Degeneration with Type 1 Macular Neovascularization: Comparison of Short-Term Outcomes.
Ophthalmologica
; 245(5): 413-420, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35834995
9.
Surgical outcomes of vitrectomy for intractable diabetic macular edema.
Graefes Arch Clin Exp Ophthalmol
; 259(2): 363-368, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-32816100
10.
Variation of vortex veins at the horizontal watershed in normal eyes.
Graefes Arch Clin Exp Ophthalmol
; 259(8): 2175-2180, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33625563
11.
REDUCED VASCULAR DENSITY IN THE CHOROID AFTER TREATMENT WITH PHOTODYNAMIC THERAPY COMBINED WITH AFLIBERCEPT IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY.
Retina
; 41(1): 156-161, 2021 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32251239
12.
TRPC5 regulates axonal outgrowth in developing retinal ganglion cells.
Lab Invest
; 100(2): 297-310, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31844148
13.
Retinal Detachment-Induced Müller Glial Cell Swelling Activates TRPV4 Ion Channels and Triggers Photoreceptor Death at Body Temperature.
J Neurosci
; 38(41): 8745-8758, 2018 10 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30143574
14.
Clinical characteristics of pachydrusen in central serous chorioretinopathy.
Graefes Arch Clin Exp Ophthalmol
; 257(6): 1127-1132, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-30852634
15.
Development of Age-Related Macular Degeneration (AMD) in the Fellow Eye of Patients with AMD Treated by Treat-and-Extend Intravitreal Therapy with Aflibercept.
Ophthalmologica
; 239(2-3): 121-127, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29169154
16.
Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy.
Graefes Arch Clin Exp Ophthalmol
; 255(10): 1891-1897, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28669041
17.
Two-Year Outcomes of a Treat-and-Extend Regimen Using Intravitreal Aflibercept Injections for Typical Age-Related Macular Degeneration.
Ophthalmologica
; 238(4): 236-242, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28898873
18.
TREAT-AND-EXTEND REGIMEN WITH AFLIBERCEPT FOR RETINAL ANGIOMATOUS PROLIFERATION.
Retina
; 36(12): 2282-2289, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27336229
19.
Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration.
Proc Natl Acad Sci U S A
; 109(36): 14598-603, 2012 Sep 04.
Artigo
Inglês
| MEDLINE | ID: mdl-22908283
20.
One-year results of treat-and-extend regimen with intravitreal faricimab for treatment-naïve neovascular age-related macular degeneration.
Jpn J Ophthalmol
; 68(2): 83-90, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38244172